Wyeth

(redirected from Wyeth Pharmaceuticals)
Also found in: Thesaurus.

Wy·eth

 (wī′ĭth), Andrew Newell 1917-2009.
American painter whose realistic canvases depict stark rural scenes. His major works include Christina's World (1948) and Tenant Farmer (1961). His father, Newell Convers Wyeth (1882-1945), was also a painter and a book illustrator.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

Wy•eth

(ˈwaɪ əθ)

n.
1. Andrew Newell, born 1917, U.S. painter.
2. his father, Newell Convers, 1882–1945, U.S. illustrator and painter.
Random House Kernerman Webster's College Dictionary, © 2010 K Dictionaries Ltd. Copyright 2005, 1997, 1991 by Random House, Inc. All rights reserved.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.Wyeth - United States painter (born in 1917)Wyeth - United States painter (born in 1917)
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
References in periodicals archive ?
Earlier in his career, Tzanis had roles of increasing responsibilities at Quintiles (now IQUVIA), Wyeth Pharmaceuticals and Pfizer.
Earlier in his career, Coyle held senior-level human resource positions at Genentech, Wyeth Pharmaceuticals and SAP America .
Theevent featured presentations from leading figures in the internationalbiotech industry, including Dr Robert R Ruffolo Jr, the retiredpresident, Research and Development for Wyeth Pharmaceuticals andcorporate senior vice president of Wyeth (now Pfizer).
Ultimately, the aim is to create an environment that allows new ideas to become successful commercial ventures that are based here in Qatar, establishing new revenue streams for the Qatari economy and closing the 'research loop'." The event featured presentations from leading figures in the international biotech industry, including Dr Robert R Ruffolo Jr, the retired President of Research and Development for Wyeth Pharmaceuticals and Corporate Senior Vice President of Wyeth (now Pfizer).
* Boehringer Ingelheim enters into an agreement with Pfizer to acquire certain assets of Wyeth Pharmaceuticals' Ft.
Mahady previously served as senior vice president of Wyeth and president of Wyeth Pharmaceuticals Inc.
and Wyeth Pharmaceuticals, which Pfizer acquired in 2009, announced it agreed to pay $45 million to the (http://www.sec.gov/litigation/complaints/2012/comp-pr2012-152-pfizer.pdf) SEC for similar charges involving alleged bribes paid to doctors and other health care workers abroad to push their products.
Pfizer inherited the problem when it bought the property from its prior owner, Wyeth Pharmaceuticals, in 2009.
He has served as president of Wyeth Pharmaceuticals, responsible for directing worldwide operations for the company's USD20bn, 38,000 employee, global pharmaceutical business.
Mr Kern worked for Wyeth Pharmaceuticals in the vaccines research unit, part of the vaccines group that were carrying out clinical trials on the vaccine Prevenar 13.
Both women were prescribed Reglan, a brand-name heartburn drug made by Wyeth Pharmaceuticals, and their pharmacists filled their prescriptions with the drug's generic versions.